Atlas Trials

Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)

Clinical trial NCT05986422 · TERMINATED

Trial details

NCT number
NCT05986422
Sponsor
Charite University, Berlin, Germany
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Post-COVID-19 Syndrome
Start date
2023-10-01
Primary completion
2025-03-14
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.